IIIB/IV non-small-cell lung cancer

Socinski MA, Schell Ml, Peterman A, et al. Phase 111 trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 2002 20 1335-1343. 

Reinmutha N, Meyerb A, Hartwigsenc D et al (2014) Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC). Lung... 

Yasuda, H., Yamaya, M., Nakayama, K., Sasaki, T, Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T, Takahashi, H., Yoshida, M., Kaneta, T., Ishizawa, K., Yamanda, S., Tomita, N., Yamasaki, M., Kikuchi, A., Kubo, H., and Sasaki, H. (2006). Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J. Clin. Oncol. 24, 688-694. 

Yasuda, H., Yamaya M., Nakayama K., et al. (2(X)6a). Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small cell lung cancer. J. Clin. Oncol. 24, 688-694. 

Payne M, Ellis P, Dunlop D, Ranson M, Danson S, Schacter L, Talbot D. DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer report of... 

---